19:03:40 EST Wed 11 Feb 2026
Enter Symbol
or Name
USA
CA



LightPath Technologies Reports Fiscal 2026 Second Quarter Financial Results

2026-02-11 16:05 ET - News Release

LightPath Technologies Reports Fiscal 2026 Second Quarter Financial Results

PR Newswire

ORLANDO, Fla., Feb. 11, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced financial results for its fiscal second quarter ended December 31, 2025.

Financial Summary:

                                                       Three Months Ended
                                                December 31,


    
     
          $ in millions   2025    2024                        % Change



 
   Revenue                       $16.4    $7.4                           120 %



 
   Gross Profit                   $6.0    $1.9                           212 %


      Operating Expenses*           $14.6    $4.4                           231 %



 
   Net Loss                     ($9.4) ($2.6)                           260 %


      Adjusted EBITDA**              $0.6  ($1.3)                           144 %




 
 * Inclusive of $7.6M change in fair value of acquisition liabilities related to the G5 acquisition.



 
 ** Reconciliation of this non-GAAP financial measure is provided below.

Second Quarter Fiscal 2026 & Subsequent Highlights:

  • Secured a $9.6 million purchase order for cooled infrared ("IR") cameras from an existing defense customer, with deliveries expected throughout calendar year 2026, further validating the strategic value of the G5 acquisition.
  • Acquired the assets of Amorphous Materials, Inc. ("AMI") in January 2026, an industrial manufacturer with complementary Chalcogenide glass melting technologies for large diameter optics.
  • Received a $4.8 million purchase order from an existing customer related to the supply of advanced IR camera systems for public safety applications for delivery in the Company's 2026 fiscal year.
  • Appointed former Luminar manufacturing executive Israel Piergiovanni as Vice President of Manufacturing to scale production across LightPath's domestic and international footprint.
  • Appointed defense industry executive Mark Caylor, former President of Northrop Grumman's Mission Systems Sector, to the Board of Directors bringing extensive defense industry expertise as LightPath evolves into a mission-critical optics supplier of choice to allied militaries.
  • Fortified balance sheet with a $60 million public offering of common stock in December 2025, with net proceeds supporting working capital, strategic investments, acquisitions and general corporate purposes.

Management Commentary

Sam Rubin, Chief Executive Officer of LightPath, said: "The second quarter of 2026 was underscored by our accelerating revenue growth on strong orders, and the recent acquisition of Amorphous Materials. Ongoing order momentum and the addition of G5 Infrared LLC's ("G5") sales of cameras and modules drove a 120% revenue improvement to a record $16.4 million for the quarter. Our $97.8 million order backlog as of the end of the second quarter is demonstrating our position as a leading pure-play provider of high value optical and imaging systems.

"Our strategy continues to be validated not only by our sales growth, but the increasing focus by the U.S. government and Department of War to eliminate reliance on certain optical components, including optical systems or strategies from certain foreign nations. The recent passage of the Fiscal Year 2026 National Defense Authorization Act (NDAA) directed the US Department of War to develop and implement a strategy by January 1, 2030, to eliminate reliance on optical glass and optical systems sourced from certain foreign nations. These restrictions extend beyond finished systems to include critical materials such as optical glass, making supply chain transparency and material provenance increasingly central to defense and aerospace program compliance. Our optical assemblies, infrared cameras, and thermal imaging systems have already been designed, manufactured, and delivered in alignment with NDAA requirements. Faced with growing supply chain risks and increased defense spending in the U.S. and Europe, we believe we are positioned as a trusted supplier for mission-critical defense applications.

"We further reinforced our domestic glass manufacturing capabilities with the recent acquisition of the assets of AMI, a U.S. based manufacturer of complementary chalcogenide glass technologies. This acquisition added incremental glass melting technology, which melts high-grade glass as large diameter plates, critical for large optics, and in particular for advanced defense and space programs. The acquisition also added glass melting capacity and a second, NDAA compliant manufacturing location for BlackDiamond glass. The acquisition further solidifies our transition from a pure component provider to a truly vertically integrated provider of subsystems and solutions for IR imaging.

"As we progress into calendar year 2026 we remain highly focused on further growing our robust $97.8 million order backlog, converting our prospective customer pipeline into orders, and scaling deliveries. We continue to intentionally shift away from Germanium optics, expanding the adoption of our proprietary BlackDiamond™ glass across critical defense markets, while continuing to move up the value chain into fully integrated IR camera systems. G5's high-end cooled infrared camera product line and several established programs of record continue to contribute to revenue growth. As we combine our growing camera portfolio with AMI's highly complementary large-diameter glass capabilities, we believe that we will create a robust offering of IR materials and optics in the industry today, all of which we expect will be compliant with the latest NDAA requirement for U.S. produced glass and optics. Taken together, we believe we are well positioned to execute on our growth strategy to deliver sustainable revenue growth and value to our shareholders."

Second Quarter Fiscal 2026 Financial Results

Revenue for the second quarter of fiscal 2026 increased 120% to $16.4 million, as compared to $7.4 million in the same quarter of the prior fiscal year. Revenue was split amongst the Company's product groups in the second quarter of fiscal 2026 and the same quarter of the prior fiscal year as follows:

                        Product Group Revenue          Second Quarter of          Second Quarter of  % Change
($ in millions)***                            Fiscal 2026                Fiscal 2025



          Infrared ("IR") Components                               $5.0                        $3.1       61 %



          Visible Components                                       $3.4                        $2.8       25 %



          Assemblies & Modules                                     $7.2                        $0.9      741 %



          Engineering Services                                     $0.7                        $0.7      (2 %)




          *** Numbers may not foot due to rounding

Gross profit increased 212% to $6.0 million, or 37% of total revenues, in the second quarter of 2026, as compared to $1.9 million, or 26% of total revenues, in the same year-ago quarter. The increase in gross margin as a percentage of revenue is primarily driven by the increase in revenue from assemblies and modules, which generally have higher margins. Gross margin on engineering services was also more favorable in the second quarter of fiscal 2026 due to a non-recurring engineering project for a defense customer. In addition, gross margins for infrared components have improved due to a more favorable mix, and the resolution of certain manufacturing yield issues that negatively impacted the second quarter of fiscal 2025.

Operating expenses for the second quarter of fiscal 2026 includes the fair value adjustment of $7.6 million related to the G5 earnout liability, which will continue to be adjusted through operating expenses until it is paid out. Excluding this amount, operating expenses increased $2.6 million, or 60%, to $7.1 million for the second quarter of fiscal 2026, as compared to $4.4 million in the same year-ago quarter. The increase was primarily due to the integration of G5 following its acquisition earlier this year, as well as increased sales and marketing spend to promote new products. Our SG&A personnel costs have also increased due to filling certain vacant executive roles and accruing for incentive compensation plans for employees.

Net loss in the second quarter of fiscal 2026 totaled $9.4 million, or $0.20 per basic and diluted share, as compared to $2.6 million, or $0.07 per basic and diluted share, in the same year-ago quarter. The year-over-year increase in net loss for the second quarter of fiscal 2026 was primarily attributable to the change in fair value of acquisition liabilities for the earnout related to the acquisition of G5.

Adjusted EBITDA* for the second quarter of fiscal 2026 was $0.6 million, as compared to an adjusted EBITDA loss of $1.3 million for the same year-ago quarter. The increase was primarily attributable to the increase in gross profit, driven by higher sales, partially offset by increased SG&A and new product development costs.

Second Quarter Fiscal 2026 Earnings Call

Management will host an investor conference call at 5:00 p.m. Eastern time today, Wednesday, February 11, 2026, to discuss the Company's second quarter fiscal 2026 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:

Q2 FY2026 Earnings Conference Call

Date: Wednesday, February 11, 2026
Time: 5:00 p.m. Eastern time
U.S. Dial-in: 1-877-425-9470
International Dial-in: 1-201-389-0878
Conference ID: 13758590
Webcast: LPTH Q2 FY2026 Earnings Conference Call

Please join at least five minutes before the start of the call to ensure timely participation.

A playback of the call will be available through Wednesday, February 25, 2026. To listen, please call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 13758590. A webcast replay will also be available using the webcast link above.

About LightPath Technologies

LightPath Technologies, Inc. (NASDAQ: LPTH) is a leading provider of next-generation optics and imaging systems for both defense and commercial applications. As a vertically integrated solutions provider with in-house engineering design support, LightPath's family of custom solutions range from proprietary BlackDiamond™ chalcogenide-based glass materials - sold under exclusive license from the U.S. Naval Research Laboratory - to complete infrared optical systems and thermal imaging assemblies. The Company's primary manufacturing footprint is located in Orlando, Florida with additional facilities in Texas, New Hampshire, Latvia and China. To learn more, please visit www.lightpath.com.

**Use of Non-GAAP Financial Measures

To provide investors with additional information regarding financial results, this press release includes references to EBITDA and adjusted EBITDA, which are non-GAAP financial measures. The Company calculates EBITDA by adjusting net income to exclude net interest expense, income tax expense or benefit, depreciation, and amortization. We also calculate adjusted EBITDA, which excludes, as applicable: (1) stock compensation expenses; (2) the loss on extinguishment of debt; (3) the effect of the non-cash income or expense associated with the mark-to-market adjustments, related to the warrants; (4) the effect of non-cash income or expenses associated with the fair value adjustments related to the acquisition earnout liabilities; and (5) the effect of foreign exchange gains or losses.

A "non-GAAP financial measure" is generally defined as a numerical measure of a company's historical or future performance that excludes or includes amounts, or is subject to adjustments, so as to be different from the most directly comparable measure calculated and presented in accordance with GAAP. The Company's management believes that these non-GAAP financial measures, when considered together with the GAAP financial measures, provide information that is useful to investors in understanding period-over-period operating results separate and apart from items that may, or could, have a disproportionately positive or negative impact on results in any particular period. Management also believes that these non-GAAP financial measures enhance the ability of investors to analyze underlying business operations and understand performance. In addition, management may utilize these non-GAAP financial measures as guides in forecasting, budgeting, and planning. Non-GAAP financial measures should be considered in addition to, and not as a substitute for, or superior to, financial measures presented in accordance with GAAP. A reconciliation of these non-GAAP financial measures with the most directly comparable financial measures calculated in accordance with GAAP is presented in the table below.

                                                            
          
            LIGHTPATH TECHNOLOGIES, INC.
                                                  Reconciliation of Non-GAAP Financial Measures and Regulation G Disclosure




                                                                                                                      
     
            (unaudited)


                                                                                                       Three Months Ended                                           Six Months Ended


                                                                                                          December 31,                                               December 31,


                                                                                            2025                                 2024                           2025                        2024



 Net loss                                                                 $
          (9,405,409)                    $
     (2,611,997)             $
     (12,298,411)             $
   (4,234,742)



 Depreciation and amortization                                                          1,235,738                                904,040                        2,454,686                     1,893,602



 Income tax provision                                                                      30,556                                 44,525                          111,826                        60,161



 Interest expense                                                                         285,023                                169,053                          553,876                       318,413



 EBITDA                                                                   $
          (7,854,092)                    $
     (1,494,379)              $
     (9,178,023)             $
   (1,962,566)



 Stock-based compensation                                                                 338,949                                241,545                          698,610                       506,020



 Loss in extinguishment of debt                                                           506,280                                                                506,280



 Change in fair value of acquisition liabilities                                        7,559,000                                                              8,841,529



 Foreign exchange loss (gain)                                                              13,526                               (39,578)                          56,068                       (4,074)



 Adjusted EBITDA                                                              $
          563,663                     $
     (1,292,412)                $
       924,464              $
   (1,460,620)



 % of revenue                                                                                   3                                    -17                      3
        %                           -9
                                                                                                 %                                     %                                                            %

Forward-Looking Statements

This press release includes statements that constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "forecast," "guidance," "plan," "estimate," "will," "would," "project," "maintain," "intend," "expect," "anticipate," "prospect," "strategy," "future," "likely," "may," "should," "believe," "continue," "opportunity," "potential," and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, without limitation, statements regarding expectations, beliefs, hopes, intentions or strategies regarding, among other things, the Company's expectations that the U.S. government will work to eliminate reliance on optical systems from certain foreign nations, as well as the Company's belief that it will be well positioned as a supplier of choice for mission-critical defense applications; the Company's ability to grow its backlog, convert its customer pipeline into orders and scale deliveries during fiscal year 2026 and beyond; the Company's ability to minimize use of Germanium optics and expand its use of BlackDiamond™ glass; the Company's expectations regarding future revenue growth; the Company's belief that it will be able to leverage AMI's large-diameter class capabilities to create a robust offering of IR materials and optics; the Company's ability to comply with NDAA requirements for U.S. produced glass and optics; the Company's ability to execute on its growth strategy to deliver revenue growth and value to its shareholders, as well as other statements that are other than historical fact. These forward-looking statements are based on information available at the time the statements are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the likelihood that the impact of varying demand for the Company products; the U.S. governments initiatives to move away from using optical systems from certain foreign nations; the inability of the Company to sustain profitable sales growth, convert inventory to cash, or reduce its costs to maintain competitive prices for its products; circumstances or developments that may make the Company unable to implement or realize the anticipated benefits, or that may increase the costs, of its current and planned business initiatives; the Company's reliance on a few key customers; the ability of the Company to obtain needed raw materials and components from its suppliers; the impact that international tariffs may have on our business and results of operations; the impact of political and other risks as a result of our sales to internal customers and/or our sourcing of materials from international suppliers; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; geopolitical tensions, the Russian-Ukraine conflict, and the Hamas-Israel war; the effects of steps that the Company could take to reduce operating costs; and those factors detailed by the Company in its public filings with the Securities and Exchange Commission (the "SEC"), including its Annual Report on Form 10-K and other filings with the SEC. Should one or more of these risks, uncertainties, or facts materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by the forward-looking statements contained herein. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Except as required under the federal securities laws and the rules and regulations of the SEC, we do not have any intention or obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.

                                                                               
          
            LIGHTPATH TECHNOLOGIES, INC.

                                                                           
          
            Condensed Consolidated Balance Sheets

                                                                                        
          
            (unaudited)




                                                                                                                                                      December 31,                    June 30,


                                                                                                                                                     2025                    2025


                                                           
          
            Assets



          Current assets:



          Cash and cash equivalents                                                                                                      $
     73,572,471         $
      4,877,036



          Trade accounts receivable, net of allowance of $34,766 and $24,495                                                                     8,583,487                 9,455,310



          Inventories, net                                                                                                                      13,491,419                12,858,838



          Prepaid expenses and deposits                                                                                                          1,330,172                 1,142,661



          Other current assets                                                                                                                      23,192                    40,150



          Total current assets                                                                                                                  97,000,741                28,373,995





          Property and equipment, net                                                                                                           15,176,577                15,864,061



          Operating lease right-of-use assets                                                                                                    7,430,787                 7,429,378



          Intangible assets, net                                                                                                                15,086,873                15,987,923



          Goodwill                                                                                                                              13,753,921                13,753,921



          Deferred tax assets, net                                                                                                                  22,240                    22,571



          Other assets                                                                                                                              87,369                    73,917



          Total assets                                                                                                                  $
     148,558,508        $
      81,505,766


                                            
          
            Liabilities and Stockholders' Equity



          Current liabilities:



          Accounts payable                                                                                                                $
     5,978,713         $
      7,421,430



          Accrued liabilities                                                                                                                   14,262,568                 5,686,396



          Accrued payroll and benefits                                                                                                           2,497,228                 2,359,152



          Operating lease liabilities, current                                                                                                   1,349,820                 1,254,062



          Loans payable, current portion                                                                                                           115,774                   172,567



          Finance lease obligation, current portion                                                                                                216,191                   206,518



          Total current liabilities                                                                                                             24,420,294                17,100,125



          Deferred tax liabilities, net                                                                                                             86,274                   152,760



          Accrued liabilities, noncurrent                                                                                                        3,300,000                   823,000



          Finance lease obligation, less current portion                                                                                           346,400                   421,363



          Operating lease liabilities, noncurrent                                                                                                8,102,873                 8,326,250



          Loans payable, less current portion                                                                                                      135,069                 4,804,990



          Total liabilities                                                                                                                     36,390,910                31,628,488





          Commitments and Contingencies





          Series G Convertible Preferred Stock; $0.01 par value; 44,000                                                                  $
     34,232,510        $
      34,232,510
shares authorized; 24,956 shares issued and outstanding





          Stockholders' equity:



          Preferred stock: Series D, $0.01 par value, voting; 500,000 shares
authorized; none issued and outstanding



          Common stock: Class A, $0.01 par value, voting; 94,500,000 shares                                                                        544,427                   429,493
authorized; 54,442,677 and 42,949,307 shares issued and outstanding



          Additional paid-in capital                                                                                                           319,121,901               244,953,346



          Accumulated other comprehensive income                                                                                                 1,283,928                   978,686



          Accumulated deficit                                                                                                                (243,015,168)            (230,716,757)



          Total stockholders' equity                                                                                                            77,935,088                15,644,768



          Total liabilities, convertible preferred stock and stockholders' equity                                                       $
     148,558,508        $
      81,505,766

                                                               
      
            LIGHTPATH TECHNOLOGIES, INC.

                                                           
 
   Condensed Consolidated Statements of Comprehensive Income (Loss)

                                                                   
          
            (unaudited)




                                                                                                                   Three Months Ended                                 Six Months Ended


                                                                                                                      December 31,                                     December 31,


                                                                                                        2025                                 2024                 2025                          2024



 Revenue, net                                                                          $
          16,351,652                      $
      7,424,829    $
       31,409,933              $
      15,825,210



 Cost of sales                                                                                     10,331,322                              5,493,998             20,907,031                      11,049,950



 Gross profit                                                                                       6,020,330                              1,930,831             10,502,902                       4,775,260



 Operating expenses:



 Selling, general and administrative                                                                5,859,461                              3,356,063             10,243,331                       6,626,646



 New product development                                                                              748,829                                764,396              1,616,257                       1,240,837



 Amortization of intangible assets                                                                    450,526                                294,711                901,050                         690,487



 Change in fair value of acquisition liabilities                                                    7,559,000                                                    8,841,529



 Loss on disposal of property and equipment                                                                17                                                        4,016                          78,437



 Total operating expenses                                                                          14,617,833                              4,415,170             21,606,183                       8,636,407



 Operating loss                                                                                   (8,597,503)                           (2,484,339)          (11,103,281)                    (3,861,147)



 Other expense:



 Interest expense, net                                                                              (285,023)                             (169,053)             (553,876)                      (318,413)



 Loss in extinguishment of debt                                                                     (506,280)                                                   (506,280)



 Other expense (income), net                                                                           13,953                                 85,920               (23,148)                          4,979



 Total other expense                                                                                (777,350)                              (83,133)           (1,083,304)                      (313,434)



 Loss before income taxes                                                                         (9,374,853)                           (2,567,472)          (12,186,585)                    (4,174,581)



 Income tax provision                                                                                  30,556                                 44,525                111,826                          60,161



 Net loss                                                                             $
          (9,405,409)                   $
      (2,611,997)  $
      (12,298,411)             $
     (4,234,742)



 Foreign currency translation adjustment                                                              212,859                              (451,035)               305,242                       (179,441)



 Comprehensive loss                                                                   $
          (9,192,550)                   $
      (3,063,032)  $
      (11,993,169)             $
     (4,414,183)



 Loss per common share (basic)                                                             $
          (0.20)                        $
      (0.07)       $
       (0.27)                 $
      (0.11)



 Number of shares used in per share calculation (basic)                                            46,998,804                             39,728,933             45,143,367                      39,645,206



 Loss per common share (diluted)                                                           $
          (0.20)                        $
      (0.07)       $
       (0.27)                 $
      (0.11)



 Number of shares used in per share calculation (diluted)                                          46,998,804                             39,728,933             45,143,367                      39,645,206

                                                                                                              
        
            LIGHTPATH TECHNOLOGIES, INC.

                                                                                             
          
       Condensed Consolidated Statements of Changes in Stockholders' Equity

                                                                                                                    
          
            (unaudited)






                                                                           Temporary Equity


                                                                               Series G                                                 Class A                                      Additional                           Accumulated                                                               Total
                                                                  Convertible                                                                                                                                     Other


                                                                           Preferred Stock                                            Common Stock                                     Paid-in                          Comprehensive                      Accumulated                        Stockholders'


                                                              Shares                                   Amount                                         Shares                          Amount                             Capital                         Income                              Deficit                                Equity



          
            Balances at June 30, 2025      24,956                  $
          
 34,232,510              42,949,307                   $
          
            429,493      $
        
   244,953,346                  $
   
        978,686           $
    
     (230,716,757)               $
   
        15,644,768



          Issuance of common stock for:



          Exercise of stock options, RSUs &                                                                            8,583                                                 86                           (86)
RSAs, net



          Issuance of common stock under                                                                           1,600,000                                             16,000                      7,878,045                                                                                                        7,894,045
private equity placement



          Issuance of common stock for                                                                               112,323                                              1,123                        348,877                                                                                                          350,000
acquisition of Visimid



          Stock-based compensation on                                                                                                                                                                349,624                                                                                                          349,624
stock options, RSUs & RSAs



          Foreign currency translation adjustment                                                                                                                                                                                           92,383                                                                     92,383



          Net loss                                                                                                                                                                                                                                                        (2,893,002)                            (2,893,002)



          
            Balances at September 30, 2025 24,956                  $
          
 34,232,510              44,670,213                   $
          
            446,702      $
        
   253,529,806                $
   
        1,071,069           $
    
     (233,609,759)               $
   
        21,437,818



          Issuance of common stock for:



          Exercise of stock options, RSUs &                                                                          120,234                                              1,203                        (1,203)
RSAs, net



          Exercise of warrants                                                                                       739,730                                              7,397                        (7,397)



          Issuance of common stock under                                                                           8,912,500                                             89,125                     65,251,709                                                                                                       65,340,834
public equity placement



          Stock-based compensation on stock                                                                                                                                                          348,986                                                                                                          348,986
options, RSUs & RSAs



          Foreign currency translation adjustment                                                                                                                                                                                          212,859                                                                    212,859



          Net loss                                                                                                                                                                                                                                                        (9,405,409)                            (9,405,409)



          
            Balances at December 31, 2025  24,956                  $
          
 34,232,510              54,442,677                   $
          
            544,427      $
        
   319,121,901                $
   
        1,283,928           $
    
     (243,015,168)               $
   
        77,935,088





          
            Balances at June 30, 2024              
          $                                        39,254,643                   $
          
            392,546      $
        
   245,140,758                  $
   
        509,936           $
    
     (215,843,575)               $
   
        30,199,665



          Issuance of common stock for:                                                                                                                                                                                                                                                                                    0



          Employee Stock Purchase Plan                                                                                 8,232                                                 82                         10,290                                                                                                           10,372



          Exercise of Stock Options, RSUs &                                                                           70,309                                                703                          (703)
RSAs, net



          Issuance of common stock for                                                                               279,553                                              2,796                        318,562                                                                                                          321,358
acquisition of Visimid



          Stock-based compensation on stock                                                                                                                                                          264,475                                                                                                          264,475
options, RSUs & RSAs



          Foreign currency translation adjustment                                                                                                                                                                                          271,594                                                                    271,594



          Net loss                                                                                                                                                                                                                                                        (1,622,745)                            (1,622,745)



          
            Balances at September 30, 2024         
          $                                        39,612,737                   $
          
            396,127      $
        
   245,733,382                  $
   
        781,530           $
    
     (217,466,320)               $
   
        29,444,719



          Issuance of common stock for:



          Exercise of Stock Options, RSUs &                                                                          229,097                                              2,291                        (2,291)
RSAs, net



          Shares issued as compensation                                                                               49,000                                                490                         89,180                                                                                                           89,670



          Stock-based compensation on stock                                                                                                                                                          231,581                                                                                                          231,581
options, RSUs & RSAs



          Foreign currency translation adjustment                                                                                                                                                                                        (451,035)                                                                 (451,035)



          Net loss                                                                                                                                                                                                                                                        (2,611,997)                            (2,611,997)



          
            Balances at December 31, 2024          
          $                                        39,890,834                   $
          
            398,908      $
        
   246,051,852                  $
   
        330,495           $
    
     (220,078,317)               $
   
        26,702,938

                                                                                          
     
          LIGHTPATH TECHNOLOGIES, INC.

                                                                                 
          
     Condensed Consolidated Statements of Cash Flows

                                                                                              
        
            (unaudited)






                                                                                                                                                                        Six Months Ended


                                                                                                                                                                          December 31,


                                                                                                                                                                 2025                                 2024



 Cash flows from operating activities:



 Net loss                                                                                                                                        $
       (12,298,411)                  $
       (4,234,742)



 Adjustments to reconcile net loss to net cash provided by (used in) operating activities:



 Depreciation and amortization                                                                                                                               2,454,686                              1,893,602



 Interest from amortization of loan issuance costs                                                                                                              90,124                                120,833



 Amortization of fair value of loan                                                                                                                             90,321



 Loss on extinguishment of debt                                                                                                                                506,280



 Change in fair value of acquisition earnout liabilities                                                                                                     8,841,529



 Loss on disposal of property and equipment                                                                                                                      4,016                                 78,437



 Stock-based compensation on stock options, RSUs & RSAs, net                                                                                                   698,610                                506,020



 Provision for credit losses                                                                                                                                  (11,573)



 Change in operating lease assets and liabilities                                                                                                            (129,028)                              (57,653)



 Inventory write-offs to allowance                                                                                                                             147,896                                135,625



 Deferred taxes                                                                                                                                               (66,155)                               (2,795)



 Changes in operating assets and liabilities, net of acquisitions:



 Trade accounts receivable                                                                                                                                     883,396                              (350,703)



 Other current assets                                                                                                                                           16,958                                 41,286



 Inventories                                                                                                                                                 (780,477)                              (13,005)



 Prepaid expenses and deposits                                                                                                                                (24,253)                             (123,598)



 Accounts payable and accrued liabilities                                                                                                                    1,257,002                              (430,923)



 Net cash provided by (used in) operating activities                                                                                                         1,680,921                            (2,437,616)





 Cash flows from investing activities:



 Purchase of property and equipment                                                                                                                          (944,909)                             (160,155)



 Proceeds from sale of equipment                                                                                                                                                                      10,648



 Net cash used in investing activities                                                                                                                       (944,909)                             (149,507)





 Cash flows from financing activities:



 Proceeds from sale of common stock from Employee Stock Purchase Plan                                                                                                                                 10,372



 Proceeds from issuance of common stock under public equity placement, net of fees                                                                          65,340,834



 Proceeds from issuance of common stock under private equity placement, net of fees                                                                          7,894,045



 Deferred payment for acquisition of Visimid                                                                                                                                                       (125,000)



 Borrowings on loans payable                                                                                                                                                                       3,000,000



 Loan issuance costs                                                                                                                                                                               (300,000)



 Payments on loans payable                                                                                                                                 (5,413,819)                             (106,486)



 Repayment of finance lease obligations                                                                                                                      (107,712)                              (89,705)



 Net cash provided by financing activities                                                                                                                  67,713,348                              2,389,181



 Effect of exchange rate on cash and cash equivalents                                                                                                          246,075                               (81,260)



 Change in cash and cash equivalents                                                                                                                        68,695,435                              (279,202)



 Cash and cash equivalents, beginning of period                                                                                                              4,877,036                              3,480,268



 Cash and cash equivalents, end of period                                                                                                          $
       73,572,471                     $
       3,201,066





 Supplemental disclosure of cash flow information:



 Interest paid in cash                                                                                                                                $
       373,398                        $
       40,838



 Income taxes paid                                                                                                                                    $
       170,272                        $
       61,427



 Supplemental disclosure of non-cash investing & financing activities:



 Purchase of equipment through finance lease arrangements                                                                                              $
       41,901                        $
       93,048



 Operating right-of-use assets acquired in exchange for operating lease liabilities                                                                   $
       435,733     
          $



 Issuance of common stock for acquisition of Visimid                                                                                                  $
       350,000                       $
       321,358

View original content to download multimedia:https://www.prnewswire.com/news-releases/lightpath-technologies-reports-fiscal-2026-second-quarter-financial-results-302685505.html

SOURCE LightPath Technologies

Contact:

Investor Relations, Lucas A. Zimmerman, MZ Group - MZ North America, LPTH@mzgroup.us, 949-259-4987

© 2026 Canjex Publishing Ltd. All rights reserved.